The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Medica Group Plc

6 Jul 2023 09:18

RNS Number : 1971F
Numis Securities Limited
06 July 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Medica Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Medica Group PLC (Joint Financial Adviser and Broker)

(d) Date dealing undertaken:

05/07/2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p Ordinary

Purchases

512,765

211.1000 GBX

211.0000 GBX

1p Ordinary

Sales

512,765

212.0000 GBX

212.0000 GBX

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

06/07/2023

Contact name:

Edward Atkins

Telephone number:

+44 020 7260 1487

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk..

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGIGDRIBGDGXL
Date   Source Headline
14th May 202012:35 pmRNSDirector/PDMR Shareholding
14th May 202012:35 pmRNSDirector/PDMR Shareholding
14th May 202012:35 pmRNSDirector/PDMR Shareholding
20th Apr 202012:58 pmRNSPosting of Annual Report and Notice of AGM
16th Apr 20203:45 pmRNSDirector/PDMR Shareholding
16th Apr 20203:45 pmRNSDirector/PDMR Shareholding
16th Apr 20203:45 pmRNSDirector/PDMR Shareholding
9th Apr 20204:12 pmRNSDirector/PDMR Shareholding
9th Apr 20204:08 pmRNSDirector/PDMR Shareholding
9th Apr 20202:00 pmRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSPreliminary results: continued double-digit growth
6th Apr 20207:00 amRNSNon-Executive Director Change
2nd Apr 20207:00 amRNSNotice of preliminary results
30th Mar 20207:00 amRNSAppointment of Chief Financial Officer
23rd Mar 20207:00 amRNSMedica Group: Market and Trading Update
23rd Mar 20207:00 amRNSMedica and Qure.ai partner to use AI
18th Mar 20207:22 amRNSAppointment of Clinical Director - Replacement
18th Mar 20207:00 amRNSAppointment of Clinical Director
12th Mar 20204:39 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSDirectorate Change
6th Mar 20209:27 amRNSNotification of Major Holdings
18th Feb 20204:41 pmRNSSecond Price Monitoring Extn
18th Feb 20204:35 pmRNSPrice Monitoring Extension
31st Jan 20209:49 amRNSNotification of Major Holdings
24th Jan 202011:20 amRNSNotification of Major Holding
24th Jan 202010:59 amRNSNotification of Major Holdings
23rd Jan 20207:00 amRNSPre-Close Trading Update
23rd Oct 201911:07 amRNSHolding(s) in Company
23rd Oct 201911:06 amRNSHolding(s) in Company
9th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20194:41 pmRNSSecond Price Monitoring Extn
1st Oct 20194:35 pmRNSPrice Monitoring Extension
30th Sep 20194:41 pmRNSSecond Price Monitoring Extn
30th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20198:24 amRNSDirector/PDMR Shareholding
9th Sep 20197:00 amRNSInterim results demonstrate strong performance
2nd Sep 20197:00 amRNSDirectorate Change
13th Aug 201912:07 pmRNSSecond Price Monitoring Extn
13th Aug 201912:02 pmRNSPrice Monitoring Extension
26th Jul 201912:07 pmRNSSecond Price Monitoring Extn
26th Jul 201912:02 pmRNSPrice Monitoring Extension
25th Jul 20197:00 amRNSPre-Close Trading Update
24th Jul 20194:41 pmRNSSecond Price Monitoring Extn
24th Jul 20194:35 pmRNSPrice Monitoring Extension
24th Jul 201912:07 pmRNSSecond Price Monitoring Extn
24th Jul 201912:02 pmRNSPrice Monitoring Extension
23rd Jul 201912:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.